Stijn de Vos (S de Vos)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Venues

Journal of diabetes research

Pharmacoepidemiology and drug safety

Cardiovascular therapeutics

Drugs - real world outcomes

Rijksuniversiteit Groningen

Rijksuniversiteit Groningen (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Rijksuniversiteit Groningen Mar 02 2020

Netherlands

Postdoctoral researcher :: Groningen Research Institute of Pharmacy

Education History

Rijksuniversiteit Groningen Sep 01 2005 - Sep 01 2010

Netherlands

BSC :: Faculty of Science and Engineering

Publications

Taichi Ochi, Stijn de Vos, Daniel J Touw, Petra Denig, Talitha L Feenstra, Eelko Hak
Tailoring Type II Diabetes Treatment: Investigating the Effect of 5-HTT Polymorphisms on HbA1c Levels after Metformin Initiation. Journal of diabetes research 2024 (2024)
Sieta T de Vries, Stijn de Vos, Monika Pury Oktora, Petra Denig
Sex disparities in medication changes after metformin initiation are associated with small, clinically non-relevant, sex differences in HbA1c levels during follow-up. Pharmacoepidemiology and drug safety 33 (5) (2024)
Taichi Ochi, Stijn de Vos, Daniel J Touw, Petra Denig, Talitha L Feenstra, Eelko Hak
Tailoring Type II Diabetes Treatment: Investigating the Effect of 5-HTT Polymorphisms on HbA1c Levels after Metformin Initiation. Journal of diabetes research 2024 (2024)
Sieta T de Vries, Stijn de Vos, Monika Pury Oktora, Petra Denig
Sex disparities in medication changes after metformin initiation are associated with small, clinically non-relevant, sex differences in HbA1c levels during follow-up. Pharmacoepidemiology and drug safety 33 (5) (2024)
Taichi Ochi, Stijn de Vos, Daniel J Touw, Petra Denig, Talitha L Feenstra, Eelko Hak
Tailoring Type II Diabetes Treatment: Investigating the Effect of 5-HTT Polymorphisms on HbA1c Levels after Metformin Initiation. Journal of diabetes research 2024 (2024)
Dennis Steenhuis, Xuechun Li, Talitha L Feenstra, Eelko Hak, Stijn de Vos
The Association between Deductibles and Cardiovascular Medication Adherence: A Retrospective Inception Cohort Study. Drugs - real world outcomes (2023)
Monika Pury Oktora, Stijn de Vos, Sieta T de Vries, Eelko Hak, Petra Denig
Sex disparities in treatment patterns after metformin initiation among patients with type 2 diabetes mellitus. Pharmacoepidemiology and drug safety (2023)
Guiling Zhou, Stijn de Vos, Catharina C M Schuiling-Veninga, Jens H J Bos, Katrien Oude Rengerink, Anna Maria Gerdina Pasmooij, Peter G M Mol, Geertruida H de Bock, Eelko Hak
Community Use of Repurposed Drugs Before and During COVID-19 Pandemic in the Netherlands: An Interrupted Time-Series Analysis. Clinical epidemiology 15 (2023)
Dennis Steenhuis, Stijn de Vos, Jens H J Bos, Eelko Hak
Role of Traditional Cardiovascular Risk Factors after Initiation of Statin Therapy: A PharmLines Inception Cohort Study. Cardiovascular therapeutics 2022 (2022)
Stijn de Vos, S Patten, E C Wit, E H Bos, K J Wardenaar, P de Jonge
Subtyping psychological distress in the population: a semi-parametric network approach. Epidemiology and psychiatric sciences 29 (2019)

Stijn de Vos.css-eqlu8i{font-size:small;padding-left:4px;} (S de Vos)

Publication Activity (10 Years)

Top Topics

Top Venues

Stijn de Vos (S de Vos)